Literature DB >> 19852664

Risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia.

Chia-Cheng Tseng1, Wen-Feng Fang, Kuo-Tung Huang, Pei-Wen Chang, Mei-Lien Tu, Yi-Ping Shiang, I S Douglas, Meng-Chih Lin.   

Abstract

OBJECTIVE: The aim of this study was to determine potential risk factors for mortality in patients with nosocomial Stenotrophomonas maltophilia pneumonia.
DESIGN: A retrospective, single-center, observational study.
SETTING: A 2400-bed tertiary teaching hospital in southern Taiwan. PATIENTS AND METHODS: This retrospective study evaluated patients (age, at least 18 years) with nosocomial pneumonia (S. maltophilia isolated from respiratory culture) who were seen at Kaohsiung Chang Gung Memorial Hospital over a 3-year period. A total of 406 patients (64% male, mean age +/- standard deviation, 69.6 +/- 14.93 years; mean duration of hospital +/- standard deviation, 57.5 +/- 39.47 days) were included.
RESULTS: Most index isolates (53.9%) were from the first sample cultured. Polymicrobial isolates were cultured from samples from 177 (43.6%) of the 406 study patients. The most common copathogen was Pseudomonas aeruginosa (53.11% of isolates). The all-cause hospital mortality rate was 42.6% (173 deaths among 406 patients). Survivors had a shorter time from admission to a positive index culture result than did nonsurvivors (26.1 vs 31.7 days; P = .04). Mortality was significantly higher among patients with malignancy (adjusted odds ratio [AOR], 2.48; 95% confidence interval [CI], 1.52-4.07; P < .001), renal disease (AOR, 2.6; 95% CI, 1.51-4.47; P = .001), intensive care unit stay (AOR, 1.72; 95% CI, 1.1-2.7; P = .018), and inadequate initial empirical antibiotic therapy (AOR, 2.17; 95% CI, 1.4-3.38; P = .001).
CONCLUSIONS: S. maltophilia pneumonia is associated with a high mortality rate and is commonly associated with concomitant polymicrobial colonization or infection. Underlying comorbidities and inadequate initial empirical antibiotic therapy substantially account for increased mortality rates.

Entities:  

Mesh:

Year:  2009        PMID: 19852664     DOI: 10.1086/648455

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  15 in total

1.  Stenotrophomonas maltophilia in the respiratory tract of medical intensive care unit patients.

Authors:  B Saugel; K Eschermann; R Hoffmann; A Hapfelmeier; C Schultheiss; V Phillip; F Eyer; K-L Laugwitz; R M Schmid; W Huber
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-07       Impact factor: 3.267

Review 2.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

3.  Monotherapy with fluoroquinolone or trimethoprim-sulfamethoxazole for treatment of Stenotrophomonas maltophilia infections.

Authors:  Yu Lin Wang; Marco R Scipione; Yanina Dubrovskaya; John Papadopoulos
Journal:  Antimicrob Agents Chemother       Date:  2013-10-21       Impact factor: 5.191

Review 4.  The effect of diabetes on mortality in critically ill patients: a systematic review and meta-analysis.

Authors:  Sarah E Siegelaar; Maartje Hickmann; Joost B L Hoekstra; Frits Holleman; J Hans DeVries
Journal:  Crit Care       Date:  2011-09-13       Impact factor: 9.097

Review 5.  Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis.

Authors:  Kristel Marquet; An Liesenborgs; Jochen Bergs; Arthur Vleugels; Neree Claes
Journal:  Crit Care       Date:  2015-02-16       Impact factor: 9.097

6.  Clinical factors associated with acquisition of resistance to levofloxacin in Stenotrophomonas maltophilia.

Authors:  Ji Hyeon Baek; Chang Oh Kim; Su Jin Jeong; Nam Soo Ku; Sang Hoon Han; Jun Yong Choi; Dongeun Yong; Young Goo Song; Kyungwon Lee; June Myung Kim
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

7.  Identification and characterization of a serious multidrug resistant Stenotrophomonas maltophilia strain in China.

Authors:  Yan Zhao; Wenkai Niu; Yanxia Sun; Huaijie Hao; Dong Yu; Guangyang Xu; Xueyi Shang; Xueping Tang; Sijing Lu; Junjie Yue; Yan Li
Journal:  Biomed Res Int       Date:  2015-01-14       Impact factor: 3.411

8.  Stenotrophomonas maltophilia Infections in Adults: Primary Bacteremia and Pneumonia.

Authors:  Mustafa Gokhan Gozel; Cem Celik; Nazif Elaldi
Journal:  Jundishapur J Microbiol       Date:  2015-08-22       Impact factor: 0.747

Review 9.  Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy.

Authors:  Anthony A Adegoke; Thor A Stenström; Anthony I Okoh
Journal:  Front Microbiol       Date:  2017-11-30       Impact factor: 5.640

10.  Effect of carbon on whole-biofilm metabolic response to high doses of streptomycin.

Authors:  Lindsay M D Jackson; Otini Kroukamp; Gideon M Wolfaardt
Journal:  Front Microbiol       Date:  2015-09-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.